Page last updated: 2024-08-16

tibolone and Bone Loss, Perimenopausal

tibolone has been researched along with Bone Loss, Perimenopausal in 94 studies

Research

Studies (94)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	26 (27.66)	18.2507
2000's	57 (60.64)	29.6817
2010's	10 (10.64)	24.3611
2020's	1 (1.06)	2.80

Authors

Authors	Studies
Malhas, R; Robinson, L	1
Black, DM; Cheung, AM; Eastell, R; Murad, MH; Rosen, CJ; Shoback, D	1
Al Nofal, A; Alahdab, F; Almasri, J; Asi, N; Barrionuevo, P; Benkhadra, K; Farah, W; Haydour, Q; Kapoor, E; Mohammed, K; Murad, MH; Muthusamy, K; Sarigianni, M; Wang, Z	1
Abad, P; Baró, F; Cancelo, MJ; Llaneza, P; Manubens, M; Mendoza, N; Quereda, F; Sánchez-Borrego, R	1
Hadji, P; Hars, O; Kalder, M; Kauka, A; Kyvernitakis, I	1
Bilezikian, J; Christiansen, C; Cummings, SR; Delmas, PD; Eastell, R; Ettinger, B; Grobbee, DE; Johnson, S; Kenemans, P; Kerzberg, EM; Kloosterboer, L; Mol-Arts, M; Mosca, L; Seifert, W; Stathopoulos, V; Verweij, P; Zanchetta, J	1
El-Hajj Fuleihan, G	1
Cummings, SR; Ettinger, B; Johnson, SR; Kenemans, P; Mol-Arts, M; Seifert, W; Van Os, S; Verweij, PJ	1
Chlebowski, RT; Prentice, R	1
Beckmann, MW; Bundred, NJ; Egberts, J; Foidart, JM; Kenemans, P; Kubista, E; Mol-Arts, M; Mulder, R; Sismondi, P; van Os, S; Vassilopoulou-Sellin, R; von Schoultz, B; Yip, CH	1
Doggrell, SA	1
Agorastos, T; Bontis, JN; Goulis, DG; Pantazis, K; Vavilis, D; Zafrakas, M	1
Baber, R; Huang, KE	1
Blake, GM; Fogelman, I; Patel, R; Rajamanohara, R; Robinson, J; Rymer, J	1
Jacobsen, DE; Melis, RJ; Olde Rikkert, MG; Verhaar, HJ	1
Kloosterboer, HJ	1
Stevenson, JC	1
Danhof, M; de Greef, R; Kerbusch, T; Peletier, LA; Post, TM; Schmidt, S	1
Jamin, C; Madelenat, P; Poncelet, C	1
Alper, T; Cetinkaya, MB; Kokcu, A; Malatyalioglu, E; Yanik, FF	1
Reginster, JY	1
Davis, SR; Davison, S	1
Fogelman, I; Robinson, J; Rymer, J	2
Bilezikian, JP; Rubin, MR	1
Lakatos, P	1
Arabi, A; Garnero, P; Porcher, R; Roux, C	1
Alvarez, K; Belzares, E; Carvajal, R; Farías, R; Ramos, J; Riera-Espinoza, G; Riera-González, G; Stanbury, G; Valderrama, I	1
Kelly, MW; Swegle, JM	1
Gorai, I	2
Arnold, A; Bartram, C; Ginsburg, J; Markou, A; Prelevic, GM; Puzigaca, Z	1
Devogelaer, JP	1
Benussi, C; Bevilacqua, G; Cappagli, B; Ciaponi, M; Gambacciani, M; Genazzani, AR; Monteleone, P	1
Ringa, V	1
László, A	1
Parfitt, AM; Riggs, BL	1
Bjarnason, NH	1
Christiansen, C; Gambacciani, M; Genazzani, AR; Schneider, HP	1
Grobbee, DE	1
Bayram, M; Kadioglu, E; Sardas, S; Soyer, C	1
Bracke, ME; Depypere, HT; Kloosterboer, HJ; Vanhoecke, BW	1
Burger, HG	1
Cebi, Z; Ozcan, J; Savan, K; Sönmez, AS; Sut, N; Utku, N; Yasar, L; Yazicioğlu, F	1
Kimmig, R; Schmidt, M	1
Ettinger, B	1
Notelovitz, M	1
Bors, K	1
Gompel, A; Piette, JC	1
Green, J; Watson, J; Wise, L	1
Glisic, A; Jeremic, K; Lazovic, A; Lazovic, G; Milosevic, V; Radivojevic, U	1
Chao, HT; Chao, KC; Cheng, MH; Wang, PH	1
Basevi, V; Maestri, E; Magrini, N; Maltoni, S; Marata, A	1
Adami, S; Davis, SR; Delmas, PD; Hensen, J; Nijland, EA; van Os, S	1
Lazovic, G; Marinkovic, J; Radivojevic, U	1
Chapman, MG; Fogelman, I; Rymer, J	1
Compston, JE; Croucher, PI; Garrahan, NJ; Lindsay, PC; Shaw, RW; Yamaguchi, K	1
Ginsburg, J; Hardiman, P; Okolo, S	1
Riggs, BL	1
Bjarnason, K; Bjarnason, NH; Christiansen, C; Haarbo, J; Rosenquist, C	1
Basdekis, K; Grigoriou, O; Karpathios, S; Katostaras, T; Lyritis, GP; Lyritis, PG; Paspati, I; Siampalioti, G; Stamatopoulos, T	1
Bennink, HJ; Berning, B; Fauser, BC; Kicovic, PM; Kuijk, CV; Kuiper, JW	1
Bartram, C; Ginsburg, J; Okolo, S; Prelevic, GM; Wood, J	1
Birkhaeuser, MH; Casez, JP; Haenggi, W; Jaeger, P; Lippuner, K	1
Antoniou, G; Botsis, D; Kalogirou, D; Karakitsos, P; Kassanos, D; Zourlas, PA	1
Affinito, P; Morgera, R; Nappi, C; Palomba, S; Pellicano, M; Sorrentino, C	1
Bell, KL; Compston, JE; Garrahan, N; Lindsay, PC; Loveridge, N; Lunt, M; Reeve, J	1
Arnala, I; Holland, N; Kicovic, PM; Kröger, H; Studd, J; Zamblera, D	1
Alexandersen, P; Bjarnason, NH; Christgau, S; Christiansen, C; Fledelius, C; Herling, C; Qvist, P; Ravn, P; Rosenquist, C	1
Alhava, E; Arnala, I; Jääskeläinen, K; Kröger, H; Parviainen, MT	1
Beardsworth, SA; Kearney, CE; Purdie, DW	1
Bersinger, NA; Birkhaeuser, MH; Haenggi, W; Mueller, MD	1
Dören, M	2
Christiansen, C	1
Bennink, HJ; Ginsburg, J; Kicovic, PM; Pavlov, PW; Prelevic, G; van der Schaaf, DB	1
Agnusdei, D; Gennari, C; Kicovic, PM; Reginster, JY	1
Balasch, J; Casals, E; Castelo-Branco, C; Figueras, F; Martínez de Osaba, MJ; Pons, F; Sanjuan, A; Vanrell, JA; Vicente, JJ	1
von Holst, T	1
Ciaponi, M; Gambacciani, M	1
Bartram, C; Brooke-Wavell, K; Ginsburg, J; Prelevic, GM	1
Birkhäuser, MH	1
Bakridan, C; Brooke-Wavell, K; Ginsburg, J; Prelevic, GM	1
Jamin, C	1
Cheng, Y; Yong, H	1
Bennink, HJ; Berning, B; Fauser, BC	1
Baylink, DJ; Freeman, R; Gallagher, JC; McClung, M	1
Cummings, S; Modelska, K	1
Bigler, JM; Burckhardt, P; Landry, M; Pache, T; Renteria, S; Thiébaud, D; Welti, HJ	1
Benhamou, CL; Fechtenbaum, J; Loiseau-Peres, S; Pelissier, C; Roux, C	1
Di Carlo, C; Morelli, M; Noia, R; Palomba, S; Pellicano, M; Zullo, F	1
Presl, J	1
Dequeker, J; Geusens, P; Gielen, J; Schot, LP	1

Reviews

34 review(s) available for tibolone and Bone Loss, Perimenopausal

Article	Year
Efficacy of Pharmacological Therapies for the Prevention of Fractures in Postmenopausal Women: A Network Meta-Analysis. The Journal of clinical endocrinology and metabolism, 2019, 05-01, Volume: 104, Issue:5 Topics: Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcitonin; Diphosphonates; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Hip Fractures; Humans; Network Meta-Analysis; Norpregnenes; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Postmenopause; Selective Estrogen Receptor Modulators; Spinal Fractures; Vitamin D	2019
New findings with old drugs for osteoporosis. Expert opinion on pharmacotherapy, 2009, Volume: 10, Issue:3 Topics: Bone Density Conservation Agents; Clinical Trials as Topic; Diphosphonates; Female; Humans; Norpregnenes; Organometallic Compounds; Osteoporosis, Postmenopausal; Stroke; Thiophenes	2009
Updated clinical recommendations for the use of tibolone in Asian women. Climacteric : the journal of the International Menopause Society, 2010, Volume: 13, Issue:4 Topics: Arthralgia; Breast Neoplasms; Cardiovascular Diseases; Contraindications; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Health Knowledge, Attitudes, Practice; Hot Flashes; Humans; Middle Aged; Musculoskeletal Diseases; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Rural Population; Sexual Dysfunctions, Psychological; Sleep Initiation and Maintenance Disorders; Urban Population	2010
Prevention of osteoporosis: one step forward, two steps back. Menopause international, 2011, Volume: 17, Issue:4 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Calcitonin; Calcium; Denosumab; Diphosphonates; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Norpregnenes; Organometallic Compounds; Osteoporosis, Postmenopausal; Practice Guidelines as Topic; Teriparatide; Thiophenes; Vitamin D	2011
[Tibolone]. Presse medicale (Paris, France : 1983), 2002, Sep-07, Volume: 31, Issue:28 Topics: Adult; Aged; Animals; Blood Coagulation; Breast; Cardiovascular Diseases; Controlled Clinical Trials as Topic; Double-Blind Method; Endometrium; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Hysterectomy; Lipid Metabolism; Lipids; Medrogestone; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Osteoporosis, Postmenopausal; Ovariectomy; Placebos; Postmenopause; Progesterone Congeners; Prospective Studies; Rabbits; Rats; Risk Factors; Surveys and Questionnaires; Time Factors	2002
[Postmenopausal hormonal treatment: conventional hormone replacement therapy or tibolone? Effects on bone]. Journal de gynecologie, obstetrique et biologie de la reproduction, 2002, Volume: 31, Issue:6 Topics: Aged; Bone Density; Double-Blind Method; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Fractures, Bone; Humans; Lumbar Vertebrae; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Patient Selection; Randomized Controlled Trials as Topic; Research Design; Time Factors; Treatment Outcome	2002
Hormone replacement therapy: current controversies. Clinical endocrinology, 2003, Volume: 58, Issue:3 Topics: Aged; Androgens; Breast Neoplasms; Cardiovascular Diseases; Cognition Disorders; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Humans; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Patient Selection; Phytotherapy; Postmenopause; Progestins; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Thrombosis	2003
New anabolic therapies in osteoporosis. Endocrinology and metabolism clinics of North America, 2003, Volume: 32, Issue:1 Topics: Aged; Bone and Bones; Bone Density; Female; Fluorides; Growth Hormone; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin-Like Growth Factor I; Male; Middle Aged; Norpregnenes; Osteoporosis; Osteoporosis, Postmenopausal; Parathyroid Hormone; Strontium	2003
[Treatment of osteoporosis]. Orvosi hetilap, 2003, Aug-03, Volume: 144, Issue:31 Topics: Bone Density; Calcitonin; Calcium Compounds; Diphosphonates; Estrogen Replacement Therapy; Female; Humans; Male; Norpregnenes; Osteoporosis; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Vitamin D	2003
Tibolone: a unique version of hormone replacement therapy. The Annals of pharmacotherapy, 2004, Volume: 38, Issue:5 Topics: Breast Neoplasms; Cardiovascular System; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Menopause; Norpregnenes; Osteoporosis, Postmenopausal; Thromboembolism	2004
[Tibolone]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 2 Topics: Animals; Bone Density; Breast; Clinical Trials as Topic; Endometrium; Female; Femoral Neck Fractures; Humans; Norpregnenes; Osteoporosis, Postmenopausal; Spinal Fractures	2004
A review of the effects of tibolone on the skeleton. Expert opinion on pharmacotherapy, 2004, Volume: 5, Issue:4 Topics: Bone Density; Drug Therapy, Combination; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Fractures, Bone; Humans; Norpregnenes; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic	2004
[Alternatives to hormone replacement therapy for menopause: an epidemiological evaluation]. Journal de gynecologie, obstetrique et biologie de la reproduction, 2004, Volume: 33, Issue:3 Topics: Climacteric; Estrogen Replacement Therapy; Female; Humans; Isoflavones; Menopause; Norpregnenes; Osteoporosis, Postmenopausal; Phytoestrogens; Plant Preparations; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators	2004
[Postmenopausal osteoporosis]. Orvosi hetilap, 2004, Jan-04, Volume: 145, Issue:1 Topics: Absorptiometry, Photon; Anabolic Agents; Calcitonin; Calcium, Dietary; Diphosphonates; Estrogen Replacement Therapy; Female; Fractures, Bone; Humans; Isoflavones; Motor Activity; Norpregnenes; Osteoporosis, Postmenopausal; Phytoestrogens; Plant Preparations; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators; Vitamin D; Weight-Bearing	2004
Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2005, Volume: 20, Issue:2 Topics: Adult; Age Factors; Aged; Aging; Anabolic Agents; Bone and Bones; Bone Density; Bone Development; Bone Remodeling; Bone Resorption; Female; Humans; Middle Aged; Models, Biological; Norpregnenes; Organometallic Compounds; Osteoblasts; Osteoporosis; Osteoporosis, Postmenopausal; Teriparatide; Terminology as Topic; Testosterone; Thiophenes; Time Factors	2005
Hormone therapy in the WHI era. The Australian & New Zealand journal of obstetrics & gynaecology, 2006, Volume: 46, Issue:2 Topics: Aged; Cardiovascular Diseases; Estrogen Replacement Therapy; Female; Forecasting; Humans; Menopause; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic; Risk Assessment; Thromboembolism; Victoria; Women's Health	2006
[The benefits and risks of hormonal replacement therapy--an update]. Gynakologisch-geburtshilfliche Rundschau, 2006, Volume: 46, Issue:4 Topics: Adult; Age Factors; Aged; Breast Neoplasms; Cardiovascular Diseases; Colonic Neoplasms; Dementia; Endometrial Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Follow-Up Studies; Humans; Meta-Analysis as Topic; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Ovarian Neoplasms; Primary Prevention; Progestins; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Risk Factors; Stroke; Thromboembolism; Time Factors	2006
Tibolone for prevention and treatment of postmenopausal osteoporosis. Maturitas, 2007, May-20, Volume: 57, Issue:1 Topics: Aged; Androgen Antagonists; Bone Density; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal	2007
Postmenopausal tibolone therapy: biologic principles and applied clinical practice. MedGenMed : Medscape general medicine, 2007, Jan-03, Volume: 9, Issue:1 Topics: Cardiovascular Diseases; Estrogens; Female; Humans; Neoplasms; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Signal Transduction	2007
[Up-to-date treatments for osteoporosis]. Orvosi hetilap, 2006, Feb-19, Volume: 147, Issue:7 Topics: Bone Density; Bone Density Conservation Agents; Bone Regeneration; Calcitonin; Calcium Compounds; Diphosphonates; Drugs, Investigational; Estrogen Replacement Therapy; Fluorides; Fractures, Bone; Humans; Norpregnenes; Organometallic Compounds; Osteoporosis; Osteoporosis, Postmenopausal; Selective Estrogen Receptor Modulators; Teriparatide; Testosterone; Thiophenes; Vitamin D	2006
Systemic lupus erythematosus and hormone replacement therapy. Menopause international, 2007, Volume: 13, Issue:2 Topics: Animals; Breast Neoplasms; Contraindications; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Lupus Coagulation Inhibitor; Lupus Erythematosus, Systemic; Norpregnenes; Osteoporosis, Postmenopausal; Progesterone; Progestins; Research Design; Risk Assessment; Thrombosis; Women's Health	2007
Effects of tibolone on the breast of postmenopausal women. Taiwanese journal of obstetrics & gynecology, 2007, Volume: 46, Issue:2 Topics: Breast; Breast Neoplasms; Estrogen Receptor Modulators; Female; Hormone Replacement Therapy; Humans; Mammography; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause	2007
Tibolone: the way to beat many a postmenopausal ailments. Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:6 Topics: Breast Neoplasms; Cardiovascular Diseases; Climacteric; Endometrium; Estrogen Receptor Modulators; Estrogens; Female; Hot Flashes; Humans; Menopause; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Randomized Controlled Trials as Topic; Risk Factors; Stroke	2008
[Postmenopausal osteoporosis: therapeutic approaches]. Minerva ginecologica, 1997, Volume: 49, Issue:3 Topics: Anabolic Agents; Bone Remodeling; Calcitonin; Calcitriol; Calcium; Diphosphonates; Estrogens; Female; Fluorides; Humans; Isoflavones; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Progestins	1997
An assessment of hormone replacement therapy to prevent postmenopausal osteoporosis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 1999, Volume: 9 Suppl 2 Topics: Case-Control Studies; Cohort Studies; Estradiol; Estradiol Congeners; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female; Humans; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic	1999
[Alternatives to hormone replacement therapy: raloxifene and tibolone]. Zeitschrift fur arztliche Fortbildung und Qualitatssicherung, 2000, Volume: 94, Issue:3 Topics: Antihypertensive Agents; Bone Density; Climacteric; Estrogen Replacement Therapy; Female; Humans; Norpregnenes; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride	2000
Postmenopausal osteoporosis management. Current opinion in obstetrics & gynecology, 2000, Volume: 12, Issue:3 Topics: Bone Density; Female; Hormone Replacement Therapy; Humans; Norpregnenes; Osteoporosis, Postmenopausal; Radiography; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Ultrasonography; Women's Health	2000
[Basic principles of hormone replacement therapy in the postmenopause]. Therapeutische Umschau. Revue therapeutique, 2000, Volume: 57, Issue:10 Topics: Administration, Cutaneous; Administration, Intravaginal; Administration, Oral; Aged; Anabolic Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estradiol Congeners; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Practice Guidelines as Topic; Progestins; Selective Estrogen Receptor Modulators; United Kingdom	2000
[Indications for hormone replacement therapy]. Therapeutische Umschau. Revue therapeutique, 2000, Volume: 57, Issue:10 Topics: Aged; Alzheimer Disease; Anabolic Agents; Breast Neoplasms; Cardiovascular Diseases; Contraindications; Endometrial Neoplasms; Estrogen Replacement Therapy; Estrogens; Female; Humans; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Progestins; Raloxifene Hydrochloride; Risk; Selective Estrogen Receptor Modulators; Thrombosis	2000
[The concept of selective action steroids]. Gynecologie, obstetrique & fertilite, 2000, Volume: 28, Issue:12 Topics: Anabolic Agents; Blood Glucose; Bone and Bones; Cardiovascular System; Climacteric; Endometrium; Female; Hormone Replacement Therapy; Humans; Menopause; Norpregnenes; Osteoporosis, Postmenopausal; Thrombosis	2000
Tibolone and its effects on bone: a review. Climacteric : the journal of the International Menopause Society, 2001, Volume: 4, Issue:2 Topics: Anabolic Agents; Animals; Bone Density; Clinical Trials as Topic; Female; Hormone Replacement Therapy; Humans; Norpregnenes; Osteoporosis, Postmenopausal; Rats	2001
Tibolone for postmenopausal women: systematic review of randomized trials. The Journal of clinical endocrinology and metabolism, 2002, Volume: 87, Issue:1 Topics: Adult; Affect; Aged; Aged, 80 and over; Double-Blind Method; Female; Hot Flashes; Humans; Lipids; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Randomized Controlled Trials as Topic; Sweating	2002
[Drugs in development for the treatment of osteoporosis: Tibolone]. Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 3 Topics: Animals; Bone Density; Endometrial Hyperplasia; Female; Humans; Norpregnenes; Organ Specificity; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone	2002
Tibolone (Livial)--a new steroid for the menopause. Drug and therapeutics bulletin, 1991, Sep-30, Volume: 29, Issue:20 Topics: Female; Half-Life; Humans; Menopause; Norpregnenes; Osteoporosis, Postmenopausal	1991

Trials

35 trial(s) available for tibolone and Bone Loss, Perimenopausal

Article	Year
Comparison of combined low-dose hormone therapy vs. tibolone in the prevention of bone loss. Climacteric : the journal of the International Menopause Society, 2016, Volume: 19, Issue:5 Topics: Absorptiometry, Photon; Bone Density; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norpregnenes; Osteoporosis, Postmenopausal; Prospective Studies; Uterine Hemorrhage	2016
The effects of tibolone in older postmenopausal women. The New England journal of medicine, 2008, Aug-14, Volume: 359, Issue:7 Topics: Aged; Aged, 80 and over; Androgen Antagonists; Bone Density; Breast Neoplasms; Colonic Neoplasms; Double-Blind Method; Endometrial Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Radiography; Risk; Spinal Fractures; Stroke	2008
Endometrial effects of tibolone in elderly, osteoporotic women. Obstetrics and gynecology, 2008, Volume: 112, Issue:3 Topics: Aged; Bone Density Conservation Agents; Carcinoma, Endometrioid; Endometrial Neoplasms; Endometrium; Estrogen Replacement Therapy; Female; Humans; Hyperplasia; Metrorrhagia; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal	2008
Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial. The Lancet. Oncology, 2009, Volume: 10, Issue:2 Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Double-Blind Method; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Neoplasm Recurrence, Local; Norpregnenes; Osteoporosis, Postmenopausal; Vasomotor System	2009
The effect of weight and weight change on the long-term precision of spine and hip DXA measurements. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2011, Volume: 22, Issue:5 Topics: Absorptiometry, Photon; Aged; Body Mass Index; Body Weight; Bone Density; Estrogen Receptor Modulators; Female; Femur Neck; Follow-Up Studies; Hip Joint; Humans; Lumbar Vertebrae; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Phantoms, Imaging; Retrospective Studies; Weight Gain	2011
Raloxifene and tibolone in elderly women: a randomized, double-blind, double-dummy, placebo-controlled trial. Journal of the American Medical Directors Association, 2012, Volume: 13, Issue:2 Topics: Absorptiometry, Photon; Academic Medical Centers; Age Factors; Aged; Aged, 80 and over; Body Mass Index; Bone Density; Bone Density Conservation Agents; Confidence Intervals; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Estrogen Receptor Modulators; Female; Follow-Up Studies; Humans; Middle Aged; Netherlands; Norpregnenes; Osteoporosis, Postmenopausal; Patient Safety; Raloxifene Hydrochloride; Reference Values; Risk Assessment; Severity of Illness Index; Treatment Outcome	2012
Application of a mechanism-based disease systems model for osteoporosis to clinical data. Journal of pharmacokinetics and pharmacodynamics, 2013, Volume: 40, Issue:2 Topics: Bone Density; Data Interpretation, Statistical; Double-Blind Method; Female; Hip; Humans; Lumbar Vertebrae; Models, Biological; Norpregnenes; Osteoblasts; Osteocalcin; Osteoporosis, Postmenopausal; Postmenopause	2013
Tibolone versus four estrogen replacement therapy protocols and plasma lipid levels in postmenopausal women. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2002, Volume: 79, Issue:1 Topics: Administration, Oral; Arteriosclerosis; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Estrogens; Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Probability; Prospective Studies; Sensitivity and Specificity; Treatment Outcome; Triglycerides; Turkey	2002
Serum leptin as a determinant of bone resorption in healthy postmenopausal women. Bone, 2003, Volume: 33, Issue:5 Topics: Aged; Biomarkers; Bone Density; Bone Resorption; Double-Blind Method; Female; Humans; Leptin; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Prospective Studies; Statistics, Nonparametric	2003
Changes in bone turnover during tibolone treatment. Maturitas, 2004, Feb-20, Volume: 47, Issue:2 Topics: Acid Phosphatase; Alkaline Phosphatase; Anabolic Agents; Biomarkers; Bone Density; Bone Remodeling; Collagen; Collagen Type I; Drug Administration Schedule; Female; Forearm; Humans; Isoenzymes; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Peptides; Tartrate-Resistant Acid Phosphatase	2004
A longitudinal evaluation of the effect of two doses of tibolone on bone density and metabolism in early postmenopausal women. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2004, Volume: 18, Issue:1 Topics: Administration, Oral; Androgen Antagonists; Bone Density; Bone Resorption; Calcium, Dietary; Drug Administration Schedule; Female; Humans; Longitudinal Studies; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Prospective Studies; Surveys and Questionnaires; Treatment Outcome	2004
Assessment of DNA damage in postmenopausal women under osteoporosis therapy. European journal of obstetrics, gynecology, and reproductive biology, 2006, Volume: 127, Issue:2 Topics: Alendronate; Bone Density Conservation Agents; Comet Assay; DNA; DNA Damage; Drug Therapy, Combination; Female; Humans; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal	2006
Effect of misoprostol on bone mineral density in women with postmenopausal osteoporosis. Prostaglandins & other lipid mediators, 2006, Volume: 79, Issue:3-4 Topics: Bone Density; Estrogen Receptor Modulators; Female; Femur Neck; Humans; Lumbar Vertebrae; Middle Aged; Misoprostol; Norpregnenes; Osteoporosis, Postmenopausal; Radiography	2006
Tibolone and osteoporosis. Archives of gynecology and obstetrics, 2007, Volume: 276, Issue:6 Topics: Aged; Bone Density; Bone Density Conservation Agents; Female; Femur Neck; Humans; Lumbar Vertebrae; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Prospective Studies	2007
Effects of tibolone and raloxifene on bone mineral density in osteopenic postmenopausal women. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2008, Volume: 19, Issue:8 Topics: Aged; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Remodeling; Collagen Type I; Double-Blind Method; Female; Hip Joint; Humans; Lumbar Vertebrae; Middle Aged; Norpregnenes; Osteocalcin; Osteoporosis, Postmenopausal; Peptides; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators	2008
Effect of tibolone on postmenopausal bone loss. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 1994, Volume: 4, Issue:6 Topics: Absorptiometry, Photon; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Prospective Studies; Radionuclide Imaging	1994
The effects of gonadotrophin-releasing hormone agonists on iliac crest cancellous bone structure in women with endometriosis. Bone, 1995, Volume: 16, Issue:2 Topics: Adult; Anabolic Agents; Biopsy; Bone Density; Bone Resorption; Drug Therapy, Combination; Endometriosis; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Ilium; Norpregnenes; Osteoporosis, Postmenopausal; Premenopause; Triptorelin Pamoate	1995
Tibolone: prevention of bone loss in late postmenopausal women. The Journal of clinical endocrinology and metabolism, 1996, Volume: 81, Issue:7 Topics: Aged; Anabolic Agents; Bone and Bones; Bone Density; Double-Blind Method; Female; Humans; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Placebos; Time Factors; Uterine Hemorrhage	1996
Prevention of post-oophorectomy bone loss with Tibolone. Maturitas, 1995, Volume: 22, Issue:3 Topics: Adult; Anabolic Agents; Bone Density; Calcium; Climacteric; Estrogen Replacement Therapy; Female; Humans; Hysterectomy; Menopause, Premature; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Ovariectomy; Prospective Studies	1995
Effects of two doses of tibolone on trabecular and cortical bone loss in early postmenopausal women: a two-year randomized, placebo-controlled study. Bone, 1996, Volume: 19, Issue:4 Topics: Absorptiometry, Photon; Anabolic Agents; Analysis of Variance; Biomarkers; Bone Density; Female; Humans; Longitudinal Studies; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal	1996
Prevention of postmenopausal bone loss using tibolone or conventional peroral or transdermal hormone replacement therapy with 17beta-estradiol and dydrogesterone. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1997, Volume: 12, Issue:5 Topics: Absorptiometry, Photon; Administration, Cutaneous; Administration, Oral; Anabolic Agents; Bone Density; Drug Therapy, Combination; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Patient Compliance; Progesterone Congeners; Retrospective Studies	1997
A randomized study of tibolone on bone mineral density in osteoporotic postmenopausal women with previous fractures. Obstetrics and gynecology, 1998, Volume: 92, Issue:4 Pt 1 Topics: Aged; Anabolic Agents; Bone Density; Calcium; Double-Blind Method; Female; Fractures, Bone; Humans; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal	1998
Clinical evaluation of the Serum CrossLaps One Step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides. Clinical chemistry, 1998, Volume: 44, Issue:11 Topics: Aged; Biomarkers; Bone Density; Bone Resorption; Collagen; Collagen Type I; Diphosphonates; Enzyme-Linked Immunosorbent Assay; Estrogen Replacement Therapy; Female; Humans; Ibandronic Acid; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Peptides; Sensitivity and Specificity	1998
Urinary bone resorption markers in monitoring treatment of symptomatic osteoporosis. Clinica chimica acta; international journal of clinical chemistry, 1999, Volume: 279, Issue:1-2 Topics: Aged; Anabolic Agents; Biomarkers; Bone Resorption; Calcium; Collagen; Collagen Type I; Double-Blind Method; Female; Humans; Hydroxyproline; Immunoenzyme Techniques; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Peptides; Placebos; Pyridines	1999
Prevention of postmenopausal bone loss at lumbar spine and upper femur with tibolone: a two-year randomised controlled trial. British journal of obstetrics and gynaecology, 1999, Volume: 106, Issue:7 Topics: Absorptiometry, Photon; Anabolic Agents; Bone Density; Female; Femur; Humans; Lumbar Vertebrae; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Prospective Studies; Treatment Outcome	1999
Decrease of serum endothelin levels with postmenopausal hormone replacement therapy or tibolone. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 1999, Volume: 13, Issue:3 Topics: Administration, Cutaneous; Administration, Oral; Anabolic Agents; Endothelins; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal	1999
Double-blind, placebo-controlled study of the effects of tibolone on bone mineral density in postmenopausal osteoporotic women with and without previous fractures. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 1999, Volume: 13, Issue:4 Topics: Absorptiometry, Photon; Aged; Anabolic Agents; Bone Density; Double-Blind Method; Female; Femur; Fractures, Bone; Humans; Lumbar Vertebrae; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Placebos; Prospective Studies	1999
Association of tibolone and fluoride displays a pronounced effect on bone mineral density in postmenopausal osteoporotic women. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 1999, Volume: 13, Issue:5 Topics: Absorptiometry, Photon; Aged; Anabolic Agents; Bone Density; Double-Blind Method; Female; Fluorides; Humans; Lumbar Vertebrae; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Patient Dropouts; Pelvic Bones	1999
Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in postmenopausal women. Maturitas, 2000, Feb-15, Volume: 34, Issue:2 Topics: Administration, Cutaneous; Anabolic Agents; Apolipoprotein A-I; Apolipoproteins B; Bone and Bones; Bone Density; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dehydroepiandrosterone; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Lipids; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Prospective Studies; Sexuality; Triglycerides	2000
Effects of 8 years of treatment with tibolone 2.5 mg daily on postmenopausal bone loss. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2001, Volume: 12, Issue:6 Topics: Absorptiometry, Photon; Alkaline Phosphatase; Anabolic Agents; Bone Density; Calcium; Creatinine; Female; Femur Neck; Hormone Replacement Therapy; Humans; Lumbar Vertebrae; Middle Aged; Norpregnenes; Osteocalcin; Osteoporosis, Postmenopausal; Prospective Studies	2001
Prevention of bone loss with tibolone in postmenopausal women: results of two randomized, double-blind, placebo-controlled, dose-finding studies. The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:10 Topics: Aged; Body Weight; Bone Density; Double-Blind Method; Endometrium; Female; Humans; Lipids; Middle Aged; Norpregnenes; Osteocalcin; Osteoporosis, Postmenopausal; Uterine Hemorrhage	2001
A 3-year study of prevention of postmenopausal bone loss: conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone. Climacteric : the journal of the International Menopause Society, 1998, Volume: 1, Issue:3 Topics: Absorptiometry, Photon; Alkaline Phosphatase; Animals; Bone Density; Calcium; Creatinine; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Femur; Horses; Humans; Hydroxyproline; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Lumbar Vertebrae; Medroxyprogesterone Acetate; Norpregnenes; Osteocalcin; Osteoporosis, Postmenopausal	1998
Randomized, double-masked, 2-year comparison of tibolone with 17beta-estradiol and norethindrone acetate in preventing postmenopausal bone loss. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2002, Volume: 13, Issue:3 Topics: Androgen Antagonists; Bone Density; Breast; Calcium; Double-Blind Method; Estradiol; Female; Humans; Lumbar Vertebrae; Middle Aged; Norethindrone; Norpregnenes; Osteoporosis, Postmenopausal; Pain; Progesterone Congeners; Statistics, Nonparametric; Uterine Hemorrhage	2002
Bone metabolism in postmenopausal women who were treated with a gonadotropin-releasing hormone agonist and tibolone. Fertility and sterility, 2002, Volume: 78, Issue:1 Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Bone Density; Bone Development; Female; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Leiomyoma; Leuprolide; Lumbar Vertebrae; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Ovariectomy; Postmenopause; Prospective Studies; Reference Values; Uterine Neoplasms	2002
Non-linear increase in vertebral density induced by a synthetic steroid (Org OD 14) in women with established osteoporosis. Maturitas, 1991, Volume: 13, Issue:2 Topics: Absorptiometry, Photon; Aged; Anabolic Agents; Bone Density; Double-Blind Method; Female; Humans; Norpregnenes; Osteoporosis, Postmenopausal; Radionuclide Imaging; Spine	1991

Other Studies

25 other study(ies) available for tibolone and Bone Loss, Perimenopausal

Article	Year
Induced menopause in women with endometriosis. Post reproductive health, 2020, Volume: 26, Issue:3 Topics: Age Factors; Endometriosis; Estrogen Receptor Modulators; Female; Gonadotropin-Releasing Hormone; Heart Disease Risk Factors; Humans; Menopause, Premature; Norpregnenes; Osteoporosis, Postmenopausal; Ovariectomy; Patient Selection; Quality of Life; Risk Adjustment	2020
Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline. The Journal of clinical endocrinology and metabolism, 2019, 05-01, Volume: 104, Issue:5 Topics: Absorptiometry, Photon; Accidental Falls; Bone Density Conservation Agents; Calcitonin; Calcium; Clinical Decision-Making; Denosumab; Diphosphonates; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Norpregnenes; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Parathyroid Hormone-Related Protein; Patient Preference; Raloxifene Hydrochloride; Risk Assessment; Risk Reduction Behavior; Selective Estrogen Receptor Modulators; Teriparatide; Vitamin D	2019
Spanish Menopause Society position statement: use of tibolone in postmenopausal women. Menopause (New York, N.Y.), 2013, Volume: 20, Issue:7 Topics: Aged; Bone Density; Cardiovascular Diseases; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Quality of Life; Randomized Controlled Trials as Topic; Sexual Dysfunction, Physiological; Societies, Medical; Spain	2013
Tibolone and the promise of ideal hormone-replacement therapy. The New England journal of medicine, 2008, Aug-14, Volume: 359, Issue:7 Topics: Androgen Antagonists; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Spinal Fractures	2008
Tibolone in older postmenopausal women. The New England journal of medicine, 2008, Nov-13, Volume: 359, Issue:20 Topics: Androgen Antagonists; Breast Neoplasms; Diagnostic Errors; Estrogen Replacement Therapy; Female; Fractures, Bone; Humans; Mammography; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Risk	2008
Hormone therapy for postmenopausal breast cancer survivors: a survey among obstetrician-gynaecologists. European journal of gynaecological oncology, 2009, Volume: 30, Issue:1 Topics: Breast Neoplasms; Data Collection; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Greece; Gynecology; Hot Flashes; Humans; Norpregnenes; Osteoporosis, Postmenopausal; Practice Patterns, Physicians'	2009
Historical milestones in the development of tibolone (Livial®). Climacteric : the journal of the International Menopause Society, 2011, Volume: 14, Issue:6 Topics: Estrogen Receptor Modulators; Female; History, 20th Century; History, 21st Century; Hot Flashes; Humans; Norpregnenes; Osteoporosis, Postmenopausal	2011
Ten years of treatment with tibolone 2.5 mg daily: effects on bone loss in postmenopausal women. Climacteric : the journal of the International Menopause Society, 2002, Volume: 5, Issue:4 Topics: Alkaline Phosphatase; Bone Density; Calcium; Case-Control Studies; Creatinine; Dose-Response Relationship, Drug; Drug Administration Schedule; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Femur Neck; Hot Flashes; Humans; Lumbar Vertebrae; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Prospective Studies; Time Factors; United Kingdom; Vagina	2002
The effect of tibolone on bone mineral density in postmenopausal women with osteopenia or osteoporosis--8 years follow-up. Maturitas, 2004, Mar-15, Volume: 47, Issue:3 Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Bone Density; Bone Diseases, Metabolic; Calcium, Dietary; Cohort Studies; Estrogen Receptor Modulators; Female; Follow-Up Studies; Humans; Longitudinal Studies; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Prospective Studies; Treatment Outcome	2004
Differential effects of alternatives to hormone replacement therapy in postmenopausal healthy women. Danish medical bulletin, 2005, Volume: 52, Issue:2 Topics: Animals; Atherosclerosis; Bone and Bones; Cardiovascular System; Estrogen Replacement Therapy; Estrogens; Female; Humans; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators	2005
Postmenopausal osteoporosis: therapeutic options. Climacteric : the journal of the International Menopause Society, 2005, Volume: 8, Issue:2 Topics: Age Factors; Anabolic Agents; Animals; Bone Density; Calcium; Contraceptives, Oral; Diphosphonates; Disease Models, Animal; Estrogen Replacement Therapy; Female; Fractures, Bone; Humans; Norpregnenes; Organometallic Compounds; Osteoporosis, Postmenopausal; Risk Factors; Selective Estrogen Receptor Modulators; Spinal Fractures; Thiophenes; Vitamin D	2005
LIFT study to continue as planned. BMJ (Clinical research ed.), 2005, Oct-08, Volume: 331, Issue:7520 Topics: Aged; Estrogen Receptor Modulators; Female; Humans; Norpregnenes; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic; Risk Factors; Spinal Fractures	2005
Tibolone and its metabolites inhibit invasion of human mammary carcinoma cells in vitro. Maturitas, 2006, Jun-20, Volume: 54, Issue:3 Topics: Adenocarcinoma; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Estrogen Receptor Modulators; Female; Humans; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Norpregnenes; Osteoporosis, Postmenopausal	2006
Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005. European journal of clinical pharmacology, 2007, Volume: 63, Issue:9 Topics: Adult; Aged; Bone Density Conservation Agents; Data Collection; Diphosphonates; Drug Prescriptions; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Practice Patterns, Physicians'; Reproducibility of Results; Risk Assessment; Time Factors; United Kingdom	2007
Still waiting and searching for answers. BMJ (Clinical research ed.), 2008, Jan-05, Volume: 336, Issue:7634 Topics: Estrogen Receptor Modulators; Female; Fractures, Bone; Humans; Norpregnenes; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic	2008
Prevention and treatment of osteoporosis. Lancet (London, England), 1993, May-22, Volume: 341, Issue:8856 Topics: Female; Humans; Norpregnenes; Osteoporosis, Postmenopausal	1993
Tibolone as an alternative to estrogen for the prevention of postmenopausal osteoporosis in selected postmenopausal women. The Journal of clinical endocrinology and metabolism, 1996, Volume: 81, Issue:7 Topics: Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal	1996
Comparative effects on bone mineral density of tibolone, transdermal estrogen and oral estrogen/progestogen therapy in postmenopausal women. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 1996, Volume: 10, Issue:6 Topics: Administration, Cutaneous; Aged; Bone Density; Estradiol; Female; Femur; Humans; Lumbar Vertebrae; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Progestins	1996
A comparative study of an estradiol-releasing vaginal ring versus tibolone in postmenopausal women: a transvaginal color Doppler study. Maturitas, 1997, Volume: 27, Issue:1 Topics: Anabolic Agents; Endometrium; Estradiol; Estrogens; Female; Humans; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Ultrasonography, Doppler, Color	1997
Cortical remodeling following suppression of endogenous estrogen with analogs of gonadotrophin releasing hormone. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1997, Volume: 12, Issue:8 Topics: Acid Phosphatase; Alkaline Phosphatase; Biomarkers; Biopsy; Bone Density; Bone Remodeling; Drug Therapy, Combination; Endometriosis; Estrogen Antagonists; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Ilium; Isoenzymes; Norpregnenes; Osteoclasts; Osteoporosis, Postmenopausal; Software; Tartrate-Resistant Acid Phosphatase; Triptorelin Pamoate	1997
Sex steroid analogs. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 1999, Volume: 9 Suppl 2 Topics: Animals; Bone Resorption; Breast Neoplasms; Estrogen Antagonists; Female; Gonadal Steroid Hormones; Hormones; Humans; Norpregnenes; Osteoporosis, Postmenopausal; Pyrrolidines; Raloxifene Hydrochloride; Receptors, Estrogen; Risk; Tamoxifen	1999
The influence of physical activity on the response of bone mineral density to 5 years tibolone. Maturitas, 2000, Jun-30, Volume: 35, Issue:3 Topics: Absorptiometry, Photon; Aged; Anabolic Agents; Bone Density; Exercise; Female; Humans; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Women's Health	2000
Effects of physical activity and menopausal hormone replacement therapy on postural stability in postmenopausal women--a cross-sectional study. Maturitas, 2001, Jan-31, Volume: 37, Issue:3 Topics: Accidental Falls; Aged; Cross-Sectional Studies; Estradiol; Exercise; Female; Hormone Replacement Therapy; Humans; Middle Aged; Muscle Tonus; Norpregnenes; Osteoporosis, Postmenopausal; Posture	2001
[The impacts of sex hormones on histomorphometric and histological appearances of bone in ovariectomized rats]. Zhonghua fu chan ke za zhi, 1999, Volume: 34, Issue:2 Topics: Anabolic Agents; Animals; Bone Density; Estrogen Replacement Therapy; Estrogens; Female; Humans; Norpregnenes; Osteoporosis, Postmenopausal; Ovariectomy; Random Allocation; Rats; Rats, Sprague-Dawley; Tibia	1999
[Tibolone--a new steroid for therapy of the climacteric syndrome and prevention of osteoporosis]. Ceskoslovenska gynekologie, 1991, Volume: 56, Issue:4 Topics: Anabolic Agents; Climacteric; Female; Humans; Norpregnenes; Osteoporosis, Postmenopausal	1991